About the Product

Full Description

\n
\n
\n
\n
\n
\n

Presentation

\nTinobac 2 gm IM Injection: Each vial contains sterile powder of Spectinomycin Hydrochloride USP equivalent to Spectinomycin 2 gm. \n \n
\n
\n

Description

\nTinobac Sterile Powder contains Spectinomycin Hydrochloride which is an aminocyclitol antibiotic produced by a species of soil microorganism designated as Streptomyces spectabilis. \n \nMicrobiology \n \nSpectinomycin Hydrochloride is an inhibitor of protein synthesis in the bacterial cell; the site of action is the 30S ribosomal subunit. In vitro studies have shown Spectinomycin Hydrochloride to be active against most strains of Neisseria gonorrhoeae \n \n
\n
\n

Indications

\nTinobac Sterile Powder is indicated in the treatment of: \n \nAcute gonorrheal urethritis and proctitis in the male \n \nAcute gonorrheal cervicitis and proctitis in the female \n \nMen and women with known recent exposure to gonorrhea should be treated as those known to have gonorrhea. \n \n
\n
\n

Dosage & Administration

\nReconstitution \nTinobac Sterile Powder, 2 grams: reconstitute with 3.2 ml of the accompanying water for injection with 0.9% Benzyl alcohol. Shake vials vigorously immediately after adding diluent and before withdrawing dose. \n \nDosage \nIntramuscular injections should be made deep into the upper outer quadrant of the gluteal muscle. \nAdults (Men and Women)-Inject 5 ml intramuscularly for a 2 gm dose.This is also the recommended dose for patients being treated after failure of previous antibiotic therapy \n \n
\n
\n

Side Effects

\nThe following reactions were observed during the single dose clinical trials: soreness at the injection site, urticaria, dizziness, nausea, chills, fever and insomnia \n \n
\n
\n

Precautions

\nThe usual precautions should be observed with atopic individuals. Prescribing Spectinomycin Sterile Powder in the absence of a proven or strongly suspected bacterial infection or a prophylactic indication is unlikely to provide benefit to the patient and increases the risk of the development of drug-resistant bacteria \n \n
\n
\n

Use in Pregnancy & Lactation

\nPregnancy Category B. Since there are no controlled studies of Spectinomycin in pregnant women, and because animal reproduction studies are not always predictive of human responses, Spectinomycin should be used during pregnancy only if clearly needed. \n \nNursing Mothers \nIt is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when Spectinomycin is administered to a nursing woman. \nPediatric Use \nSafety and effectiveness in the pediatric population have not been established. \n \n
\n
\n

Over Dose

\nInformation on overdosage in humans is not available. Hemodialysis has been reported to aid in the removal of intravenously administered Spectinomycin from the body. \n \n
\n
\n

Commercial Pack

\nTinobac 2 gm IM Injection: Each vial contains sterile powder of Spectionmycin Hydrochloride USP equivalent to Spectinomycin 2 gm accompanied with an ampoule of 3.2 ml Water For Injection with Benzyl alcohol 0.9% m/v and a 5 ml sterile disposable syringe. \n \n
\n
\n
\n
\n
\n

Reviews:


No Review



Cart

0 Items

0
Cart 0 Item
close
close

Your purchase will delivered in 1 shipment

Express delivery
Empty

Your shopping bag is empty. Start shopping now.